FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ASS1-NCS1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ASS1-NCS1
FusionPDB ID: 7258
FusionGDB2.0 ID: 7258
HgeneTgene
Gene symbol

ASS1

NCS1

Gene ID

445

23413

Gene nameargininosuccinate synthase 1neuronal calcium sensor 1
SynonymsASS|CTLN1FLUP|FREQ
Cytomap

9q34.11

9q34.11

Type of geneprotein-codingprotein-coding
Descriptionargininosuccinate synthaseargininosuccinate synthetase 1citrulline-aspartate ligaseepididymis secretory sperm binding proteinneuronal calcium sensor 1frequenin homologfrequenin-like proteinfrequenin-like ubiquitous protein
Modification date2020031320200313
UniProtAcc

P00966

Main function of 5'-partner protein: FUNCTION: One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues. {ECO:0000305|PubMed:18473344, ECO:0000305|PubMed:27287393, ECO:0000305|PubMed:8792870}.

P62166

Main function of 5'-partner protein: FUNCTION: Neuronal calcium sensor, regulator of G protein-coupled receptor phosphorylation in a calcium dependent manner. Directly regulates GRK1 (RHOK), but not GRK2 to GRK5. Can substitute for calmodulin (By similarity). Stimulates PI4KB kinase activity (By similarity). Involved in long-term synaptic plasticity through its interaction with PICK1 (By similarity). May also play a role in neuron differentiation through inhibition of the activity of N-type voltage-gated calcium channel (By similarity). {ECO:0000250}.
Ensembl transtripts involved in fusion geneENST idsENST00000493984, ENST00000352480, 
ENST00000372393, ENST00000372394, 
ENST00000372398, ENST00000458469, 
ENST00000493042, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score3 X 5 X 4=606 X 6 X 4=144
# samples 46
** MAII scorelog2(4/60*10)=-0.584962500721156
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/144*10)=-1.26303440583379
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ASS1 [Title/Abstract] AND NCS1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ASS1 [Title/Abstract] AND NCS1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ASS1(133355836)-NCS1(132963237), # samples:2
Anticipated loss of major functional domain due to fusion event.ASS1-NCS1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ASS1-NCS1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneASS1

GO:0007623

circadian rhythm

28985504



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:133355836/chr9:132963237)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ASS1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NCS1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000352480ASS1chr9133355836+ENST00000372398NCS1chr9132963237+575191091418469
ENST00000372394ASS1chr9133355836+ENST00000372398NCS1chr9132963237+616013192531827524
ENST00000372393ASS1chr9133355836+ENST00000372398NCS1chr9132963237+5754913751421448

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000352480ENST00000372398ASS1chr9133355836+NCS1chr9132963237+0.0018628370.9981371
ENST00000372394ENST00000372398ASS1chr9133355836+NCS1chr9132963237+0.0033940840.9966059
ENST00000372393ENST00000372398ASS1chr9133355836+NCS1chr9132963237+0.0017681410.9982318

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ASS1-NCS1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ASS1chr9133355836NCS1chr91329632371319355DIVENRFIGMKSRVTEKEVQQWYKGF
ASS1chr9133355836NCS1chr9132963237910300DIVENRFIGMKSRVTEKEVQQWYKGF
ASS1chr9133355836NCS1chr9132963237913279DIVENRFIGMKSRVTEKEVQQWYKGF

Top

Potential FusionNeoAntigen Information of ASS1-NCS1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ASS1-NCS1_133355836_132963237.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ASS1-NCS1chr9133355836chr9132963237910HLA-A30:08GMKSRVTEK0.99430.6511817
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:01RVTEKEVQQW0.99980.95511222
ASS1-NCS1chr9133355836chr9132963237910HLA-B58:02RVTEKEVQQW0.99920.89711222
ASS1-NCS1chr9133355836chr9132963237910HLA-B58:01RVTEKEVQQW0.99810.91841222
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:03RVTEKEVQQW0.99630.981222
ASS1-NCS1chr9133355836chr9132963237910HLA-B15:17RVTEKEVQQW0.99620.77321222
ASS1-NCS1chr9133355836chr9132963237910HLA-B15:16RVTEKEVQQW0.98640.8891222
ASS1-NCS1chr9133355836chr9132963237910HLA-A32:13RVTEKEVQQW0.96480.88221222
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:01SRVTEKEVQQW0.99990.93061122
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:03SRVTEKEVQQW0.99950.97661122
ASS1-NCS1chr9133355836chr9132963237910HLA-B58:01SRVTEKEVQQW0.99950.88141122
ASS1-NCS1chr9133355836chr9132963237910HLA-B44:03RVTEKEVQQWY0.80820.83491223
ASS1-NCS1chr9133355836chr9132963237910HLA-B44:08RVTEKEVQQW0.77130.79621222
ASS1-NCS1chr9133355836chr9132963237910HLA-A30:01GMKSRVTEK0.99430.7839817
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:10RVTEKEVQQW0.99980.95511222
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:04RVTEKEVQQW0.99930.69041222
ASS1-NCS1chr9133355836chr9132963237910HLA-B58:06RVTEKEVQQW0.99880.95511222
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:02RVTEKEVQQW0.99620.94131222
ASS1-NCS1chr9133355836chr9132963237910HLA-A32:01RVTEKEVQQW0.9940.89021222
ASS1-NCS1chr9133355836chr9132963237910HLA-B15:24RVTEKEVQQW0.94720.90651222
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:10SRVTEKEVQQW0.99990.93061122
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:04SRVTEKEVQQW0.99980.6941122
ASS1-NCS1chr9133355836chr9132963237910HLA-B57:02SRVTEKEVQQW0.99930.90541122
ASS1-NCS1chr9133355836chr9132963237910HLA-B15:53RVTEKEVQQWY0.96870.72171223
ASS1-NCS1chr9133355836chr9132963237910HLA-B44:07RVTEKEVQQWY0.80820.83491223
ASS1-NCS1chr9133355836chr9132963237910HLA-B44:13RVTEKEVQQWY0.80820.83491223
ASS1-NCS1chr9133355836chr9132963237910HLA-B44:26RVTEKEVQQWY0.80820.83491223

Top

Potential FusionNeoAntigen Information of ASS1-NCS1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ASS1-NCS1_133355836_132963237.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ASS1-NCS1chr9133355836chr9132963237910DRB1-0101ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0101VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0103ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0103VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0103NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-0103IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-0105ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0105VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0107ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0107VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0109ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0109VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0109NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-0109IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-0111ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0111VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0113ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0113VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0115ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0115VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0115NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-0115IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-0117ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0117VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0119ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0119VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0121ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0121VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0125ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0125VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0127ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0127VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0129ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0129VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0131ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0131VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0431ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0443ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0447ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0447VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0447IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-0454ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0454VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0454NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-0454IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-0475ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0475VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0482ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0482VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0486ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0486VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-0807ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0813ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0815ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0824ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0830ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0832ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-0837ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1001ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1003ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1105ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1111ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1130ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1130VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1130NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1130IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1145ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1164ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1172ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1216ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1216VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1304NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1326ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1326VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1332NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1332ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1338ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1348NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1348ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1363ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1365ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1367ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1367VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1375NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1375ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1393NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1403ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1427ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1440ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1446ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1446VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1463ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1467ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1477ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1502ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1502VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1508ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1508VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1511ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1511VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1514ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1514VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1515ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1515VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1515IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1519ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1519VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1526ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1526VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1527ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1527VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1530ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1531ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1531VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1534ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1534VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1538ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1538VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1539ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1539VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1544ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1544VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1547ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1547VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1601ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1601VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1601IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1601NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1602ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1602VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1603ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1603VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1603IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1603NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1604ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1604VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1604NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1604IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1605ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1605VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1605IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1607ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1607VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1607IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1608ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1608VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1608IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1608NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1609ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1609VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1609IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1609NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1610ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1610VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1610IVENRFIGMKSRVTE116
ASS1-NCS1chr9133355836chr9132963237910DRB1-1610NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB1-1611ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1611VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1612ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1612VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1614ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1614VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB1-1616ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB1-1616VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB5-0102ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB5-0102VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB5-0103ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB5-0103VENRFIGMKSRVTEK217
ASS1-NCS1chr9133355836chr9132963237910DRB5-0103NRFIGMKSRVTEKEV419
ASS1-NCS1chr9133355836chr9132963237910DRB5-0104ENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB5-0108NENRFIGMKSRVTEKE318
ASS1-NCS1chr9133355836chr9132963237910DRB5-0108NVENRFIGMKSRVTEK217

Top

Fusion breakpoint peptide structures of ASS1-NCS1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
2412FIGMKSRVTEKEVQASS1NCS1chr9133355836chr9132963237910

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ASS1-NCS1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN2412FIGMKSRVTEKEVQ-7.9962-8.1096
HLA-B14:023BVN2412FIGMKSRVTEKEVQ-5.70842-6.74372
HLA-B52:013W392412FIGMKSRVTEKEVQ-6.83737-6.95077
HLA-B52:013W392412FIGMKSRVTEKEVQ-4.4836-5.5189
HLA-A11:014UQ22412FIGMKSRVTEKEVQ-10.0067-10.1201
HLA-A11:014UQ22412FIGMKSRVTEKEVQ-9.03915-10.0745
HLA-A24:025HGA2412FIGMKSRVTEKEVQ-6.56204-6.67544
HLA-A24:025HGA2412FIGMKSRVTEKEVQ-5.42271-6.45801
HLA-B44:053DX82412FIGMKSRVTEKEVQ-7.85648-8.89178
HLA-B44:053DX82412FIGMKSRVTEKEVQ-5.3978-5.5112
HLA-A02:016TDR2412FIGMKSRVTEKEVQ-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of ASS1-NCS1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ASS1-NCS1chr9133355836chr91329632371122SRVTEKEVQQWCCCGAGTTACCGAGAAGGAGGTCCAGCAGTGGT
ASS1-NCS1chr9133355836chr91329632371222RVTEKEVQQWGAGTTACCGAGAAGGAGGTCCAGCAGTGGT
ASS1-NCS1chr9133355836chr91329632371223RVTEKEVQQWYGAGTTACCGAGAAGGAGGTCCAGCAGTGGTACA
ASS1-NCS1chr9133355836chr9132963237817GMKSRVTEKGAATGAAGTCCCGAGTTACCGAGAAGG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ASS1-NCS1chr9133355836chr9132963237116IVENRFIGMKSRVTETCGTGGAGAACCGCTTCATTGGAATGAAGTCCCGAGTTACCGAGA
ASS1-NCS1chr9133355836chr9132963237217VENRFIGMKSRVTEKTGGAGAACCGCTTCATTGGAATGAAGTCCCGAGTTACCGAGAAGG
ASS1-NCS1chr9133355836chr9132963237318ENRFIGMKSRVTEKEAGAACCGCTTCATTGGAATGAAGTCCCGAGTTACCGAGAAGGAGG
ASS1-NCS1chr9133355836chr9132963237419NRFIGMKSRVTEKEVACCGCTTCATTGGAATGAAGTCCCGAGTTACCGAGAAGGAGGTCC

Top

Information of the samples that have these potential fusion neoantigens of ASS1-NCS1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAASS1-NCS1chr9133355836ENST00000352480chr9132963237ENST00000372398TCGA-A8-A0A4-01A

Top

Potential target of CAR-T therapy development for ASS1-NCS1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ASS1-NCS1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ASS1-NCS1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource